Anticoagulant Therapy for Percutaneous Coronary Intervention

Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study

(2009) Ludovic Drouet et al.   AMERICAN HEART JOURNAL

Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents

(2009) Jiro Aoki et al.   CIRCULATION

Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice

(2009) Tracy Y. Wang et al.   CIRCULATION

Bleeding in Patients Undergoing Percutaneous Coronary Intervention

(2009) Sameer K. Mehta et al.   Circulation-Cardiovascular Interventions

Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

(2009) George Dangas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout mice

(2009) Subrata Chakrabarti et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

(2009) Marc S Sabatine et al.   LANCET

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

(2009) Roxana Mehran et al.   LANCET

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

(2008) Mark Y. Chan et al.   CIRCULATION

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial

(2008) G. Montalescot et al.   EUROPEAN HEART JOURNAL

Influence of Timing of Clopidogrel Treatment on the Efficacy and Safety of Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

(2008) A. Michael Lincoff et al.   JACC-Cardiovascular Interventions

The CIAO (Coronary Interventions Antiplatelet-based Only) Study

(2008) Eugenio Stabile et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy

(2008) Harvey D. White et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

(2008) Adnan Kastrati et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

(2007) Spencer B. King et al.   CIRCULATION